Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature
- PMID: 19190339
- PMCID: PMC2819227
- DOI: 10.1158/0008-5472.CAN-08-2741
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature
Abstract
Tumors may be initiated and maintained by a cellular subcomponent that displays stem cell properties. We have used the expression of aldehyde dehydrogenase as assessed by the ALDEFLUOR assay to isolate and characterize cancer stem cell (CSC) populations in 33 cell lines derived from normal and malignant mammary tissue. Twenty-three of the 33 cell lines contained an ALDEFLUOR-positive population that displayed stem cell properties in vitro and in NOD/SCID xenografts. Gene expression profiling identified a 413-gene CSC profile that included genes known to play a role in stem cell function, as well as genes such as CXCR1/IL-8RA not previously known to play such a role. Recombinant interleukin-8 (IL-8) increased mammosphere formation and the ALDEFLUOR-positive population in breast cancer cell lines. Finally, we show that ALDEFLUOR-positive cells are responsible for mediating metastasis. These studies confirm the hierarchical organization of immortalized cell lines, establish techniques that can facilitate the characterization of regulatory pathways of CSCs, and identify potential stem cell markers and therapeutic targets.
Figures
Similar articles
-
Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.Stem Cells. 2011 Jan;29(1):32-45. doi: 10.1002/stem.563. Stem Cells. 2011. PMID: 21280157
-
Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1.Anticancer Res. 2022 Mar;42(3):1199-1205. doi: 10.21873/anticanres.15586. Anticancer Res. 2022. PMID: 35220209
-
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.Clin Cancer Res. 2010 Jan 1;16(1):45-55. doi: 10.1158/1078-0432.CCR-09-1630. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028757 Free PMC article.
-
Breast cancer stem cells and intrinsic subtypes: controversies rage on.Curr Stem Cell Res Ther. 2009 Jan;4(1):50-60. doi: 10.2174/157488809787169110. Curr Stem Cell Res Ther. 2009. PMID: 19149630 Review.
-
Stem cells in the human breast.Cold Spring Harb Perspect Biol. 2010 May;2(5):a003160. doi: 10.1101/cshperspect.a003160. Cold Spring Harb Perspect Biol. 2010. PMID: 20452965 Free PMC article. Review.
Cited by
-
Heterogeneity of chemokine cell-surface receptor expression in triple-negative breast cancer.Am J Cancer Res. 2015 Mar 15;5(4):1295-307. eCollection 2015. Am J Cancer Res. 2015. PMID: 26101698 Free PMC article.
-
Low molecular weight heparin ablates lung cancer cisplatin-resistance by inducing proteasome-mediated ABCG2 protein degradation.PLoS One. 2012;7(7):e41035. doi: 10.1371/journal.pone.0041035. Epub 2012 Jul 23. PLoS One. 2012. PMID: 22844424 Free PMC article.
-
ΔNp63α-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells.Cancer Res. 2013 Jan 15;73(2):1020-30. doi: 10.1158/0008-5472.CAN-12-2862. Epub 2012 Dec 14. Cancer Res. 2013. PMID: 23243027 Free PMC article.
-
The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the "Seed" and the "Soil"?Int J Breast Cancer. 2012;2012:209748. doi: 10.1155/2012/209748. Epub 2011 Nov 3. Int J Breast Cancer. 2012. PMID: 22295241 Free PMC article.
-
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis.Oncotarget. 2016 Aug 23;7(34):54157-54173. doi: 10.18632/oncotarget.11022. Oncotarget. 2016. PMID: 27494839 Free PMC article.
References
-
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. - PubMed
-
- Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730–7. - PubMed
-
- Glinsky GV. Stem cell origin of death-from-cancer phenotypes of human prostate and breast cancers. Stem Cell Rev. 2007;3:79–93. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA101860-05/CA/NCI NIH HHS/United States
- P30 CA046592-21/CA/NCI NIH HHS/United States
- P30 CA046592-20S3/CA/NCI NIH HHS/United States
- R01 CA101860-01A1/CA/NCI NIH HHS/United States
- P30 CA046592-13/CA/NCI NIH HHS/United States
- P30 CA046592/CA/NCI NIH HHS/United States
- P30 CA046592-16/CA/NCI NIH HHS/United States
- R01 CA101860-04/CA/NCI NIH HHS/United States
- P30 CA046592-20/CA/NCI NIH HHS/United States
- P30 CA046592-12/CA/NCI NIH HHS/United States
- CA66233/CA/NCI NIH HHS/United States
- P30 CA046592-19S1/CA/NCI NIH HHS/United States
- R01 CA129765-02/CA/NCI NIH HHS/United States
- P30 CA046592-17/CA/NCI NIH HHS/United States
- R01 CA101860-03/CA/NCI NIH HHS/United States
- P30 CA046592-19/CA/NCI NIH HHS/United States
- P30 CA046592-21S1/CA/NCI NIH HHS/United States
- P30 CA046592-18/CA/NCI NIH HHS/United States
- P30 CA046592-20S2/CA/NCI NIH HHS/United States
- R01 CA129765-01A1/CA/NCI NIH HHS/United States
- 5 P 30 CA46592/CA/NCI NIH HHS/United States
- R01 CA101860-02/CA/NCI NIH HHS/United States
- P30 CA046592-15/CA/NCI NIH HHS/United States
- R01 CA129765/CA/NCI NIH HHS/United States
- R01 CA101860/CA/NCI NIH HHS/United States
- P30 CA046592-20S1/CA/NCI NIH HHS/United States
- CA101860/CA/NCI NIH HHS/United States
- P30 CA046592-14/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
